Not All Medicare Enrollees Are Continuing Treatment For Opioid Use Disorder
March 3, 2025
On February 12, 2025, the U.S. Department of Health and Human Services Office of Inspector General (OIG) published this data brief which found that not all Medicare enrollees are continuing medication treatment for opioid use disorder (MOUD). Discontinuing MOUD increases the risk of relapse, overdose, and death—outcomes that have plagued the United States amid its decades-long opioid epidemic.
Want To Read More?
This content is exclusive to RECADEMY members.
RECADEMY is a comprehensive, research-based, online learning collaborative designed to provide critical information about emerging substance use disorder treatment topics and models of care.
Sign in or join the RECADEMY community for free today.
